The postmarketing safety profile of varicella vaccine.

@article{Sharrar2000ThePS,
  title={The postmarketing safety profile of varicella vaccine.},
  author={Robert G Sharrar and Philip Larussa and Susan A Galea and Sharon Projansky Steinberg and Ann Sweet and R M Keatley and Mary Ellen Wells and Wendy P. Stephenson and Anne A. Gershon},
  journal={Vaccine},
  year={2000},
  volume={19 7-8},
  pages={916-23}
}
The postmarketing safety profile of varicella vaccine was evaluated by analyzing selected adverse experience reports temporally associated with the administration of the vaccine. There were 7963 reports voluntarily submitted to Merck for an overall reporting rate of 5.0 per 10000 doses of vaccine distributed. A varicella zoster virus (VZV) identification program detected the presence of the Oka vaccine strain in three individuals with an immune deficiency - two with pneumonia and one with… CONTINUE READING
86 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 86 extracted citations

Similar Papers

Loading similar papers…